Fig. 2.
Survival in patients with an initial duration of remission longer than 12 months treated at relapse with either high-dose therapy and autografting (solid line, n = 22) or conventional salvage therapy (n = 42, dashed line). (A) Overall survival. Log-rank P < .20. (B) Event-free survival. Log-rank P < .20.